Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SILKEBORG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   1.9% 2.3% 3.6% 1.6% 1.9% 4.4% 14.3% 10.8%   Credit score (0-100)   71 66 52 74 69 46 15 23   Credit rating   A BBB BBB A A BBB BB BB   Credit limit (kDKK)   0.3 0.0 0.0 4.6 0.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,831 2,749 2,895 3,445 3,466 4,192 0.0 0.0   EBITDA   683 473 226 605 437 875 0.0 0.0   EBIT   401 167 12.7 392 224 141 0.0 0.0   Pre-tax profit (PTP)   206.3 85.4 -54.4 341.6 176.7 132.6 0.0 0.0   Net earnings   109.3 73.4 -67.2 264.1 147.7 107.8 0.0 0.0   Pre-tax profit without non-rec. items   206 85.4 -54.4 342 177 133 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,749 2,583 2,561 2,538 2,515 169 0.0 0.0   Shareholders equity total   874 947 880 1,044 992 300 24.8 24.8   Interest-bearing liabilities   3,133 2,919 2,302 2,124 2,064 63.3 165 165   Balance sheet total (assets)   4,804 4,628 4,161 4,083 3,775 1,207 190 190   Net Debt   3,132 2,893 2,297 2,117 2,045 -190 165 165     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,831 2,749 2,895 3,445 3,466 4,192 0.0 0.0   Gross profit growth   8.3% -2.9% 5.3% 19.0% 0.6% 20.9% -100.0% 0.0%   Employees   4 5 7 7 7 6 0 0   Employee growth %   0.0% 25.0% 40.0% 0.0% 0.0% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,804 4,628 4,161 4,083 3,775 1,207 190 190   Balance sheet change%   -3.0% -3.7% -10.1% -1.9% -7.5% -68.0% -84.3% 0.0%   Added value   683.1 472.8 225.6 605.4 437.0 874.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -563 -661 -426 -426 -426 -3,913 -169 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.2% 6.1% 0.4% 11.4% 6.5% 3.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.2% 3.6% 0.3% 9.5% 5.7% 5.7% 0.0% 0.0%   ROI %   8.8% 3.9% 0.3% 11.3% 6.7% 7.8% 0.0% 0.0%   ROE %   13.3% 8.1% -7.4% 27.5% 14.5% 16.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.2% 20.5% 21.2% 25.6% 26.3% 24.8% 13.0% 13.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   458.5% 612.0% 1,017.9% 349.6% 468.0% -21.7% 0.0% 0.0%   Gearing %   358.5% 308.1% 261.5% 203.4% 208.1% 21.1% 666.7% 666.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.9% 2.7% 2.6% 2.3% 2.3% 1.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.4 0.2 0.3 0.2 1.0 0.0 0.0   Current Ratio   0.2 0.4 0.2 0.3 0.2 1.0 0.0 0.0   Cash and cash equivalent   1.6 25.3 5.2 7.6 18.9 253.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -947.4 -734.2 -892.3 -825.1 -1,160.9 -10.9 -82.6 -82.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   171 95 32 86 62 146 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   171 95 32 86 62 146 0 0   EBIT / employee   100 33 2 56 32 24 0 0   Net earnings / employee   27 15 -10 38 21 18 0 0